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1. Introduction 
Pyruvate dehydrogenase (PDH) !s an interconvertible 
enzyme which exists in active or inactive forms, PDH, 
and PDHb, respectively [l-3] . In heart muscle and 
in kidney from normal fed rats, PDH, amounts to 
about 2/3 of total PDH, whereas in starvation or in 
acute diabetes it is about l/6 [4] . Under the latter 
conditions, the plasma levels of free fatty acids (FFA) 
and of ketone bodies are increased, and it was sug- 
gested that these metabolites favor the transition 
PDH, + PDHb [4] . In the present investigation, the 
role of FFA and of ketone bodies in the control of 
the PDH system was studied isolated perfused rat 
hearts. 
2. Experimental 
Male Sprague Dawley rats (150 to 200 g; Fa. Wiga, 
Munich, Ottobrunn) fed ad libitum with a standardized 
chow diet (Labortierfutter 57 Z, J. Zahn II, Hocken- 
heim, Germany) were used. Hearts were prepared in 
nembutal anaesthesia (5 mg/lOO g body weight i.p.) 
according to the Langendorff procedure [ 51 modified 
by Morgan et al. [6] . After pre-perfusion (open 
system) with 8 ml of substrate-free Krebs-Henseleit 
bicarbonate buffer [7] saturated with 95% 02-S% COZ, 
the hearts were perfused with 15 ml of recirculating 
Krebs-Henseleit buffer, pH 7.4, containing 2% bovine 
albumin (Cohn Fr. V., Serva Entwicklungslabor, 
Heidelberg) and 5 mM glucose. Palmitate (Fa. 
Schuchardt, Munich) was added as an albumin com- 
plex prepared according to Bode and Klingenberg [8] . 
The hearts were perfused for 20 min at 37” with a 
North-Holland Publishing Company - Amsterdam 
constant pressure of 60 mm Hg maintained by an 
excenter pump (Fa. Deuster, Munich). Flow rates 
(12-15 ml/min) and frequency of heart contractions 
(240-28O/min) remained constant during the per- 
fusion period. Glucose, lactate, pyruvate, acetoacetate 
and /3-hydroxybutyrate were determined in HC104- 
deproteinized and neutralized perfusate samples by 
standard enzymatic procedures 191. Acetate assays 
were carried out according to Holz and Bergmeyer 
[lo] , FFA determinations by a modified [ 1 I] Dun- 
combe procedure [12] . L-fl-Hydroxybutyrate was 
measured by titration with NaOH. Protein was deter- 
mined by the Biuret Method using Labtrol serum 
(DADE Div. Miami USA) as a standard. After freeze 
clamping the beating hearts according to Wollenberger 
et al. [ 131 tissue homogenates were prepared by 
pulverizing the frozen hearts and homogenisation 
with a high speed tissue desintegrator for small samples 
(Ultra Turrax TP 10 N, Fa. Jahnke and Kunkel, 
Staufen, Germany). PDH activities were measured by 
the dismutation assay as described previously [4]. 
Enzymes, coenzymes and D,L-P-hydroxybutyrate 
were products of Boehringer Mannheim GmbH. 
Lithium-acetoacetate was prepared according to Hall 
[14]. Quinine salt of L-b-hydroxybutyrate kindly 
donated by Prof. Lynen, Munich, was converted to 
the sodium salt [ 151 . All other reagents were from 
E. Merck, Darrnstadt. The significance of differences 
between means was calculated by the t test method. 
3. Results and discussion 
Addition of palmitate, acetoacetate, P-hydroxy- 
butyrate, or acetate decreased glucose uptake of the 
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July 1971 
Metabolite changes of perfusate 
Additions to 
(A pmole per g w.w./20 min) 
Group 
5 mM glucose 
N 
Glucose Pahnitate Acetoacetate 
D,L-p-Hydroxy- 
butyrate 
Acetate Lactate Pyruvate L/P 
A none 
B 1 mM palmitate 
C 4 mM acetoacetate 
D 10 mM D,L;O- 6 -17.8 
hydroxybutyrate** +0.8 
E 8 mM acetate 6 -15.3 
k1.2 
F 8 mM acetate + 
4 mM acetoacetate 
G 4 mM L-p-hydroxy- 
butyrate 
6 -28.0 
iO.3 
5 -18.7 
*2.9 
6 -17.8 
+2.8 
5 -15.8 
i2.6 
6 -26.: 
i4.4 
-6.93 - 
io.77 
- -22.1 
+1.3 
- -21.1 
i2.6 
- _ 
+7.50 - 
k2.4 
-23.8 - 
i2.6 
- -52.3 
+3.0 
+6.67 -39.5 
*l.O k4.4 
+4.27 +1.24 
+0.64 to.13 
3.5 
+0.2 
+14.3 +0.77 
+2.37 kO.18 
6.77 *to.30 
*0.75 
+11.4 +1.20 
i2.70 *0.33 
+5.98 +0.54 
t-o.89 eO.06 
+9.04 WO.74 
*3.19 io.25 
+7.77 +I.36 
il.34 *o. 14 
19.7 
t1.6 
27.2 
t6.6 
11.3 
*2.1 
11.5 
Zt1.G 
13.4 
*2.0 
6.0 
izO.8 
Effect of fatty acids and ketone bodies on glucose metabolism of isolated perfused heart from fed rats. The reduction of glucose 
uptake in groups B-F vs. A is statistically significant at 0.001 < p < 0.01. Group G vs. A = n.s. 
* Corresponding to4 mM D-fl-hydroxybutyrate by enzymatic determination. 
hearts (table 1). Lactate production and lactate/ 
pyruvate concentration ratios were increased which 
agrees with earlier observations [for review, see 161 . 
So far, diminished rates of glucose uptake have 
been reported only under conditions where insulin 
was available either endogenously bound to the heart 
muscle or by addition to the medium. After a per- 
fusion period of about half an hour most of endogenous 
insulin bound to rat heart muscle is removed [ 17, 181. 
Since in our studies the pre-perfusion period was 
only 2-3 min, it is assumed that sufficient amounts 
of endogenous insulin-were still present to allow the 
fatty acid induced inhibition of glucose uptake. ‘The 
rates of acetoacetate and fl-hydroxybutyrate utilization 
were similar to those reported by Williamson and 
Krebs [ 191. Acetate was also rapidly used. However, 
acetate uptake was diminished when added together 
with acetoacetate indicating preferential utilization 
of acetoacetate as substrate. Similarly, acetate has 
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has been shown to be ineffective in competing for the 
oxidation of palmitate in rat hearts [20]. 
PDH, activity in perfused hearts accounts for 
about 60% of total PDH activity (fig. 1) corresponding 
well with the values found in heart muscle rapidly 
removed from normally fed rats by freeze-clamping 
[4] . Furthermore, 20 min of perfusion with 5 mM 
glucose did not change either total activity or the 
active portion of the enzyme. When palmitate, 
acetoacetate, D,L-P-hydroxybutyrate or acetate was 
added to the perfusate PDH, activity decreased to 
about half of the control value 0, < 0.001). The total 
PDH activity was unchanged exept in the experiments 
with acetate, where both total PDH and PDH, were 
decreased. However, the decrase in PDH, relative to 
total activity was also highly significant in the presence 
of acetate. As also shown in fig. 1 perfusion with the 
unphysiological L-form of fi-hydroxybutyrate did not 
result in a lowering of PDH,. Perfusions with 4 mM 
Volume 15, number 4 FEBS LETTERS July 1971 
&‘F 
3c 
20 
10 
6 r 
A t 
POH, in % 
total 57.7 27.2 255 27.3 3 0.1 32.9 63.4 
activity r 3.3 : 2.8 : 3.5 r 4.1 + 2.8 *- 3.3 r 5.2 
Fig. 1. Effect of FFA and ketone bodies on PDH activities in isolated perfused heart from fed rats. Total height of bars represents 
total PDH activity (after activation) and the height of hatched areas the PDH, activity. Mean values + S.E.M. are given. Results ae 
expressed asnmoles acetylphosphate formed mg protein/min. Groups A-G are the same as in table 1. 
lithium chloride instead of lithium acetoacetate showed 
no differences as compared to controls. 
The present experiments with isolated perfused rat 
hearts support our hypothesis that an increased supply 
of long chain FFA is responsible for the conversion of 
active to inactive PDH in heart muscle [4] . Moreover, 
ketone bodies and acetate have been shown to exert 
the same effect. The mechanism for this interconver- 
sion is not yet clear, but it is obviously related to 
metabolic alterations induced by the oxidation of 
fatty acids and ketone bodies, substrates which are 
readily utilized by heart muscle. So far, the diminished 
pyruvate oxidation observed upon perfusion with 
fatty acids or ketone bodies has been ascribed to 
feedback inhibition of PDH by acetyl-CoA and/or 
NADH [21-231. However, interconversion from 
active to inactive PDH may also be considered as a 
mechanism for the control of pyruvate oxidation. 
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